The results indicate that promoter methylation plays an important role in the down-regulation of ABI3 expression in thyroid cell lines and thyroid carcinoma tissues and explain, at least in part, why ABI3 silencing might occur in a cancer- and tissue-specific manner. Here, ABI3 is linked to cancer.